載入...
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
Roland Buhl,1 Donald Banerji21Pulmonary Department, Mainz University Hospital, Mainz, Germany; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAAbstract: Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic antag...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2012-10-01
|
| 叢編: | International Journal of COPD |
| 在線閱讀: | http://www.dovepress.com/profile-of-glycopyrronium-for-once-daily-treatment-of-moderate-to-seve-a11367 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|